Screener
Dyne Therapeutics, Inc. DYN Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest income | 8,757 | 7,100 |
| Interest expense | (4,202) | — |
| Other expense, net | (133) | (89) |
| Total other income, net | 4,422 | 7,011 |
| Net loss | $(120,854) | $(115,361) |
| Net loss per share—basic and diluted | $(0.73) | $(1.05) |
| Weighted average common shares outstanding, basic and diluted | 165,036,604 | 109,911,628 |
| Comprehensive loss: |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s other income (expense)?
- Dyne Therapeutics, Inc. (DYN) reported other income (expense) of $4.42M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Dyne Therapeutics, Inc.'s other income (expense) decreased by 36.9% year-over-year, from $7.01M to $4.42M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s other income (expense) has grown at a 133.9% compound annual growth rate (CAGR), from $734K to $21.97M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Dyne Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude